Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

Positive Association Between Circulating 25-hydroxyvitamin D Levels And Prostate Cancer Risk: New Findings From An Updated Meta-analysis

Yong-hua Xu, Xiaoping Shao, Y. Yao, L. Xu, Liang Chang, Zhuojuan Jiang, Zhaofen Lin
Published 2014 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
PurposeTo investigate and clarify the relationship between circulating 25-hydroxyvitamin D level and prostate cancer risk.MethodsWe conducted the meta-analysis to better evaluate the association. Terms “25-Hydroxyvitamin D”/“vitamin D” and “prostate cancer” were used for literature search.ResultsWe identified 21 relevant publications from databases of PubMed and MEDLINE and included 11,941 cases and 13,870 controls in the meta-analysis. Overall studies revealed a significant 17 % elevated risk of prostate cancer for individuals with higher level of 25-hydroxyvitamin D (OR = 1.17, 95 % CI = 1.05–1.30, P  = 0.004), and no publication bias was found in the calculations (P  = 0.629). Subgroup analysis confirmed the association from nested case–control study group, studies from USA group and studies using serum samples group (nested case–control studies: OR = 1.17, 95 % CI = 1.08–1.27, P < 0.001; USA: OR = 1.15, 95 % CI = 1.03–1.29, P = 0.017; serum: OR = 1.20, 95 % CI = 1.01–1.42, P = 0.042); moreover, sensitivity tests also indicated significant results in studies from Europe and studies conducting with plasma samples after exclusion of some influential single study from the analysis, respectively (Europe: OR = 1.21, 95 % CI = 1.04–1.40, P = 0.014; plasma: OR = 1.13, 95 % CI = 1.00–1.27, P = 0.05).ConclusionsOur meta-analysis, for the first time, suggested significant positive relationship between high level of 25-hydroxyvitamin D and increased risk of prostate cancer, reminding us that more concern should be taken into account during assessing the effect of 25-hydroxyvitamin D.
This paper references
10.1158/1055-9965.EPI-07-0672
Lack of Association between Serum Levels of 25-Hydroxyvitamin D and the Subsequent Risk of Prostate Cancer in Finnish Men
J. Faupel-Badger (2007)
10.1002/PROS.20570
Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25‐hydroxyvitamin D and 1,25‐dihydroxyvitamin D, and prostate cancer risk
B. Mikhak (2007)
10.1093/CARCIN/BGI049
22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer.
K. Nakagawa (2005)
Vitamin Drelated genes , serum vitamin D concentrations and prostate cancer risk
J ahn (2009)
10.1007/s10552-012-9948-3
Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case–control study
Johan Brändstedt (2012)
10.1158/1055-9965.EPI-06-0777
Interaction of Factors Related to the Metabolic Syndrome and Vitamin D on Risk of Prostate Cancer
P. Tuohimaa (2007)
10.1136/bmj.315.7109.629
Bias in meta-analysis detected by a simple, graphical test
M. Egger (1997)
10.1002/ijc.27327
Associations of circulating 25‐hydroxyvitamin D with prostate cancer diagnosis, stage and grade
R. Gilbert (2012)
10.1016/j.jsbmb.2004.03.063
Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer
E. Jacobs (2004)
10.1210/JC.2007-0298
The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis.
A. Pittas (2007)
10.1093/carcin/bgp055
Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.
J. Ahn (2009)
The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates.
W. Grant (2006)
10.1007/s10552-010-9706-3
Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose–response meta-analysis
R. Gilbert (2010)
10.1016/j.ypmed.2013.08.026
Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis.
L. Yin (2013)
10.1023/A:1008923802001
Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)
M. Ahonen (2004)
10.1001/JAMA.291.16.1999
Effect of Vitamin D on falls: a meta-analysis.
H. Bischoff-Ferrari (2004)
10.1002/ijc.11375
Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries
P. Tuohimaa (2004)
10.3945/jn.109.118539
Estimation of total usual calcium and vitamin D intakes in the United States.
R. Bailey (2010)
10.1023/A:1008875819232
Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States)
A. Nomura (2004)
10.1371/JOURNAL.PMED.0040103
A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer
H. Li (2007)
Prostate lC, Ovarian Cancer screening trial Project t (2008) serum vitamin D concentration and prostate cancer risk: a nested casecontrol study
J ahn (2008)
A Systematic Review and Meta-analysis
P. Chan (2010)
risk and prediagnostic serum 25hydroxyvitamin D levels ( Finland )
tenkanen l (2000)
10.1093/aje/kwp022
Serum Vitamin D and Risk of Prostate Cancer in a Case-Control Analysis Nested Within the European Prospective Investigation into Cancer and Nutrition (EPIC)
R. Travis (2009)
10.1158/1055-9965.EPI-04-0319
Risk of Prostate Cancer in a Randomized Clinical Trial of Calcium Supplementation
J. Baron (2005)
10.1007/s10552-010-9557-y
Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men
C. Barnett (2010)
10.2337/db07-1122
25-Hydroxyvitamin D, IGF-1, and Metabolic Syndrome at 45 Years of Age
E. Hyppönen (2008)
10.1023/B:CACO.0000024245.24880.8a
Plasma 1,25-Dihydroxy- and 25-Hydroxyvitamin D and Subsequent Risk of Prostate Cancer
E. Platz (2004)
10.1016/0197-2456(86)90046-2
Meta-analysis in clinical trials.
R. Dersimonian (1986)
Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study.
P. Pazdiora (2011)
Plasma 1 , 25dihydroxyand 25hydroxyvitamin D and subsequent risk of prostate cancer
Porojnicu aC (2007)
Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
J. Ma (1998)
( hawaii , United states )
JM Ordonez-Mena (2013)
25-hydroxyvitamin D, IgF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 57(2):298–305
e hypponen (2008)
10.1158/0008-5472.CAN-06-1876
A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers.
R. Stolzenberg-Solomon (2006)
10.2337/DB07-1122
25-hydroxyvitamin D, insulin-like growth factor 1 and metabolic syndrome at age 45y: a cross-sectional study in the 1958 British birth cohort
E. Hyppönen (2007)
10.1136/gut.2006.095463
Folate: a magic bullet or a double edged sword for colorectal cancer prevention?
Y. Kim (2006)
thomas Mg, Binderup l, hague a (2000) apoptosis is induced by the active metabolite of vitamin
Diaz gD (2000)
10.1093/jnci/djs189
Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.
I. Shui (2012)
Key tJ (2009) serum vitamin D and risk of prostate cancer in a case-control analysis nested within the european Prospective
MV arguelles (2009)
10.1007/BF02558827
Vitamin D
H. Pols (2007)
10.3322/caac.21208
Cancer statistics, 2014
R. Siegel (2014)
Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
G. Díaz (2000)
10.3390/molecules15031762
Vitamins and Prostate Cancer Risk
K. V. Donkena (2010)
The effect of vitamin D on falls: a meta-analysis
Z. Qiu (2013)
10.1002/ijc.22553
A prospective study of dietary calcium, dairy products and prostate cancer risk (Finland)
P. Mitrou (2007)
10.1002/ijc.25439
Meta‐analysis of observational studies of serum 25‐hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma
S. Gandini (2011)
Vitamin D and cardiovascular outcomes: a systematic review and metaanalysis
MB elamin (2011)
10.1158/1055-9965.EPI-11-0403
Serum 25-Hydroxy Vitamin D and Prostate Cancer Risk in a Large Nested Case–Control Study
D. Albanes (2011)
10.1158/1055-9965.EPI-12-1332
Serum 25-Hydroxyvitamin D and Cancer Risk in Older Adults: Results from a Large German Prospective Cohort Study
J. Ordóñez-Mena (2013)
10.3945/ajcn.112.039222
Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studies.
H. Meyer (2013)
Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate
J Ma (1998)
10.1007/s10552-004-1661-4
The epidemiology of vitamin D and cancer incidence and mortality: A review (United States)
E. Giovannucci (2004)
sJ, schatzkin a, hayes RB, Prostate lC, Ovarian trial Project t (2009) Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis
J ahn (2009)
10.1038/nrc1144
Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms
S. A. Lamprecht (2003)
10.1097/MCO.0b013e32833192bc
Folic acid fortification: a double-edged sword
M. Lucock (2009)
10.1093/jnci/djp260
Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer.
D. Albanes (2009)
Metaanalysis of longitudinal studies: serum vitamin D and prostate cancer risk
Yin l (2009)
10.1093/jnci/djn152
Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
J. Ahn (2008)
10.1093/JNCI/92.23.1910
Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
P. Stattin (2000)
Vitamins and prostate cancer risk. Molecules 15(3):1762–1783
KV Donkena (2010)
10.1177/146642400412400518
Understanding prostate cancer
E. Siddiqui (2004)
10.2307/2533446
Operating characteristics of a rank correlation test for publication bias.
C. Begg (1994)
10.1016/j.ejca.2009.12.030
Plasma 25-hydroxyvitamin D and prostate cancer risk: the multiethnic cohort.
S. Park (2010)
10.1007/BF00051795
Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)
M. Braun (2004)
Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis.
S. Mohr (2011)
10.1210/jc.2011-0398
Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis.
M. Elamin (2011)
10.1093/JNCI/22.4.719
Statistical aspects of the analysis of data from retrospective studies of disease.
N. Mantel (1959)
10.1016/j.ejca.2011.02.007
A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.
S. Chuang (2011)
10.1136/bmj.b3692
Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials
H. Bischoff-Ferrari (2009)
10.1016/J.LUNGCAN.2006.11.013
Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
A. Porojnicu (2007)
10.1016/j.arr.2012.02.004
Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies
B. Schöttker (2013)
10.1126/SCIENCE.279.5350.563
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
June M. Chan (1998)
10.1016/j.canep.2009.10.014
Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk.
L. Yin (2009)
10.1038/nrc2196
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics
Kristin K. Deeb (2007)



This paper is referenced by
10.1093/IJE/DYW148
Metabolomics analysis of serum 25-hydroxy-vitamin D in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
Shakira M. Nelson (2016)
10.1007/s10552-016-0740-7
Vitamin D, PTH, and calcium in relation to survival following prostate cancer
Johan Brändstedt (2016)
10.1007/s11154-017-9415-2
The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms
M. Moukayed (2017)
10.1016/j.cct.2019.04.015
Vitamin D supplementation for prevention of cancer: The D2d cancer outcomes (D2dCA) study.
R. Chatterjee (2019)
10.1017/S0007114515004353
A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk
M. Deschasaux (2015)
10.1111/cen.13062
Association between serum 25‐hydroxyvitamin D and serum sex steroid hormones among men in NHANES
G. Anic (2016)
10.1002/cncr.30634
Serum 25‐hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men
T. Layne (2017)
10.1080/13685538.2020.1764927
Association between metabolic syndrome, hepatic steatosis, and testosterone deficiency: evidences from studies with men and rodents.
D. A. M. Hermoso (2020)
10.1007/978-3-030-32656-2_2
Dietary Carcinogens and DNA Adducts in Prostate Cancer.
Medjda Bellamri (2019)
10.1530/EC-18-0283
Circulating vitamin D level and mortality in prostate cancer patients: a dose–response meta-analysis
Zhen-yu Song (2018)
10.1177/0884533617721687
Dietary Supplements Commonly Used by Cancer Survivors: Are There Any Benefits?
M. Marian (2017)
To Study the Association of Vitamin D and Inflammation in Prostate Cancer Patients of Northern India
K. Taneja (2020)
10.1038/s41391-018-0070-9
Prostate cancer risk factors in black and white men in the NIH-AARP Diet and Health Study
T. Layne (2018)
10.1007/s10654-018-0428-2
Circulating 25-hydroxyvitamin D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival
S. Weinstein (2018)
10.1002/ijc.32105
Vitamin D levels and cancer incidence in 217,244 individuals from primary health care in Denmark
F. J. Vojdeman (2019)
10.1055/a-0774-8809
The Effect of Vitamin D Supplementation on Prostate Cancer: A Systematic Review and Meta-Analysis of Clinical Trials.
Simin Shahvazi (2019)
10.1016/J.NUTRES.2019.03.010
Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study.
K. Zhu (2019)
10.1080/19381980.2016.1187349
Do studies reporting ‘U’-shaped serum 25-hydroxyvitamin D–health outcome relationships reflect adverse effects?
W. Grant (2016)
10.17816/JOWD6734-19
The effect of vitamin D on women’s reproductive health
M. Bakleicheva (2018)
10.20333/2500136-2018-4-13-21
REPRODUCTIVE HEALTH AND CARDIOMETABOLIC RISK
V. Chulkov (2018)
10.14740/WJNU317W
Association of Vitamin D With Prostate Carcinoma: A Single Institutional Observational Study
S. K. Choubey (2017)
10.1201/9781315100913-11
10 Prostate Cancer
M. Bratton (2017)
10.26719/emhj.20.035
Effect of serum 25-hydroxyvitamin D level on lung, breast, colorectal and prostate cancers: a nested case-control study.
A. Acikgoz (2020)
10.1152/physrev.00014.2015
Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.
S. Christakos (2016)
10.1007/978-3-030-46227-7_3
Vitamin D Status and Cancer Incidence, Survival, and Mortality.
Hanseul Kim (2020)
10.3390/nu12092638
Disparities in Head and Neck Cancer: A Case for Chemoprevention with Vitamin D
Mirela Ibrahimovic (2020)
10.1016/J.RHUM.2018.07.005
Recommandations françaises de stratégies thérapeutiques pour la prévention et le traitement de l’ostéoporose induite par la castration dans le cancer de la prostate
K. Briot (2019)
10.5772/65101
Skeletal and Extraskeletal Benefits of Vitamin D
E. Casado (2017)
Roles of Solar UVB and Vitamin D in Reducing Cancer Risk and Increasing Survival.
W. Grant (2016)
10.1210/er.2018-00126
Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions
R. Bouillon (2018)
10.1007/978-3-030-48088-2_28
Building a Prostate Cancer Lifestyle Medicine Program
Zach Dovey (2020)
10.1016/j.jbspin.2018.09.017
French recommendations for osteoporosis prevention and treatment in patients with prostate cancer treated by androgen deprivation.
K. Briot (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar